Abstract
Cholesteatoma of the middle ear is the disease, the course and prognosis of which can not be considered without taking into account the patients age. In pediatric otorhinolaryngology, such patients require special attention due to the aggressiveness of cholesteatoma in children. The rapid growth and a high number of recurrences after surgical treatment are features of the course of this disease in children. The causes of the aggressiveness of this disease in children have not been studied. Objective: to identify clinical and immunological features in children with middle ear cholesteatoma in different age groups that contribute to the aggressive course of the disease. A retrospective analysis of 143 medical case reports of children from 1 to 17 years old who received surgical treatment of middle ear cholesteatoma was carried out in the Department of othorhinolaryngology (St. Petersburg State Pediatric Medical University) from 2000 to 2018. Comparative analysis of clinical manifestation, anamnesis of ear disease, concomitant diseases, immunological reactivity (the content of lymphocytes, their subpopulations and interleukin-2 in peripheral blood) and results of surgical treatment of middle ear cholesteatoma in different age groups has been performed. Cholesteatoma is more aggressive in young children. Frequent infections of the upper respiratory tract, eustachian tube dysfunctions, immune disorders in children under 7 years of age lead to an unfavorable course and prognosis of middle ear cholesteatoma.
Highlights
Ярким примером заболевания, течение и прогноз которого невозможно рассматривать без учета возраста больного, является холестеатома среднего уха
Cholesteatoma of the middle ear is the disease, the course and prognosis of which can not be considered without taking into account the patients age
Objective: to identify clinical and immunological features in children with middle ear cholesteatoma in different age groups that contribute to the aggressive course of the disease
Summary
Течение и прогноз которого невозможно рассматривать без учета возраста больного, является холестеатома среднего уха. С целью выявить в различных возрастных группах клинические и иммунологические особенности у детей с холестеатомой среднего уха, способствующие агрессивному течению заболевания, проведен ретроспективный анализ историй болезни 143 пациентов от 1 года до 17 лет, оперированных по поводу холестеатомы среднего уха в отделении оториноларингологии СПбГПМУ с 2000 по 2018 г. Оценивались и сравнивались в различных возрастных группах особенности клинической манифестации холестеатомы среднего уха, анамнез заболевания уха, сопутствующая соматическая патология, состояние иммунологической реактивности (содержание лимфоцитов, их субпопуляций и интерлейкина-2 в периферической крови), результаты хирургического лечения.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
